Antimicrobial resistance (AMR) has emerged as a major threat to public health. Resistant infections can be difficult, and sometimes, impossible to treat. Misuse and overuse of antibiotics is the main cause of AMR. Lack of clean water and sanitation and inadequate infection prevention and control promotes the spread of microbes, some of which can be resistant to antimicrobial treatment. India carries one of the largest burdens of drug-resistant pathogens worldwide. 

Diagnostic cultures take 3-5 days and during this time medication gets initiated without the culture results being known. This can accelerate AMR. Hence, it becomes critical to have diagnostic technologies that can undertake rapid pathogen identification, which will lead to quicker, targeted treatment and medication, ultimately eliminating AMR. 

Omix has developed a next generation molecular biology-based diagnostics platform for rapid detection of infectious diseases. Its DNA-based proprietary tests allow detection of infection-causing bugs within a few hours. Omix provides specific information on AMR, enabling targeted treatment. More importantly, its proprietary ambient stable protocols make it possible to use it in under-resourced settings.